{"id":1068273,"date":"2022-08-13T01:57:07","date_gmt":"2022-08-13T05:57:07","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/clene-to-host-visionary-ms-results-call-and-webcast-on-august-15\/"},"modified":"2024-08-18T11:45:11","modified_gmt":"2024-08-18T15:45:11","slug":"clene-to-host-visionary-ms-results-call-and-webcast-on-august-15","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/clene-to-host-visionary-ms-results-call-and-webcast-on-august-15.php","title":{"rendered":"Clene to Host VISIONARY-MS Results Call and Webcast on August 15"},"content":{"rendered":"<p><![CDATA[SALT LAKE CITY, Aug.  12, 2022  (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ: CLNN) along with its subsidiaries \u201cClene\u201d and its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative disease, today announced that it will present results from its Phase 2 VISIONARY-MS trial at 7:30 a.m. EDT on Monday, August 15.]]><\/p>\n<p>Read this article:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/08\/12\/2497792\/0\/en\/Clene-to-Host-VISIONARY-MS-Results-Call-and-Webcast-on-August-15.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Clene to Host VISIONARY-MS Results Call and Webcast on August 15\">Clene to Host VISIONARY-MS Results Call and Webcast on August 15<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Read this article: Clene to Host VISIONARY-MS Results Call and Webcast on August 15 <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/clene-to-host-visionary-ms-results-call-and-webcast-on-august-15.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068273","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068273"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068273"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068273\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068273"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068273"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068273"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}